The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...
The global single nucleotide polymorphism (SNP) genotyping market size was valued at USD 7.24 billion in 2025 and is predicted to hit around USD 19.48 billion by 2034, rising at a 11.7% CAGR, a study ...
Comprehensive residue-level mapping of amyloid-beta recognition reveals how sequence variants, post-translational modifications, and aggregation state shape antibody specificity, thereby guiding ...
Spatial omics is a new generation of technologies that allow scientists to study cells in their original location within ...
As rural hospitals across the United States continue to face persistent workforce shortages, international direct hire nurses are playing a growing role in maintaining access to care and strengthening ...
“In GA, light is not transduced into electrical signals because of a loss of photoreceptors, which leads to an absolute scotoma (blind spot). 2,3 The PRIMA neurostimulation system replaces the lost ...
In a warming corner of Iceland, tiny soil microbes are quietly rewriting one of Earth’s most fundamental life-support systems ...
According to Precedence Research, the global RNA analysis market size is expected to be worth USD 23.39 billion by 2035, increasing from USD 10.21 billion in 2026, with a strong CAGR of 9.65% from ...
The global nanotechnology-based medical devices market size was US$ 2.90 billion in 2021. The global nanotechnology-based medical devices market is forecast to grow to US$ 35.15 billion by 2030, ...
Santa Clara University is extending its “test-optional” policy for first-year and transfer students until 2026. Scores on the SAT or ACT (including the enhanced version) are not required for students ...
Genetic data from 139,416 human embryos were used to characterize chromosomal abnormalities, called aneuploidies, that underlie many cases of pregnancy loss. This approach revealed a relationship ...
PD-1 blockade reprograms both innate and adaptive immunity in people living with HIV and cancer, inducing interferon-driven antiviral responses that reduce the HIV reservoir. A pre-existing type I ...